Le Lézard
Classified in: Health
Subjects: SBS, MAT

Arizona Cannabis Cultivation & Production Lease Opportunity Available


PHOENIX, July 16, 2020 /PRNewswire/ -- iLAVA of Arizona owns 100% of a cultivation and processing license and is now requesting proposals for a financed operator with cultivation experience to enter one of America's top cannabis markets. Our ideal partner must be focused on quality control, compliance, and has experience designing and building out cannabis cultivation operations. The Arizona medical marijuana program and upcoming adult use initiative do not limit cultivation canopy size or limit plant count. Arizona's population is over 7.2 million as of 2019.

Over 190,000 lbs. of medical marijuana is sold per year in the Arizona cannabis market. In May 2020, cannabis sales in Arizona's medical dispensaries reached $93 million, growing seven percent from April. There are currently over 245,000 registered medical marijuana patients in Arizona and patient cards are valid for 2 years.

The iLAVA management team opened The Downtown Dispensary in 2013 which has won Best of Tucson® in 2015, 2016, 2017, and 2019. The iLAVA team currently operates 2 dispensaries and an industrial medical marijuana cultivation/production facility with 120+ employees in Tucson. iLAVA products are also distributed in 80+ dispensaries statewide including the bestselling topical in Arizona, iLAVA Touch, in addition to our vape cartridges & extracts. Arizona currently has 126 operating dispensaries statewide.

The iLAVA distribution network and the product expertise of our retail staff will be available to our potential partners. This opportunity includes cultivation and can include marijuana product manufacturing & distribution depending on negotiated deal terms.

Due to Arizona's medical marijuana laws and our internal practices, any qualified individuals must be able to pass a criminal background check and provide proof of funding upon request.

This opportunity is being listed by the iLAVA management team (Moe Asnani & Chip Boyden) and not by a broker or third party.

Interested parties who want to enter the Arizona market can email their proposals to [email protected]. Visit ilava.com to learn more about us.

Media contact:
Natalie Beckley
[email protected] 
602-621-0648

SOURCE iLAVA


These press releases may also interest you

at 22:54
Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

at 22:03
Progressive Familial Intrahepatic Cholestasis Treatment Market Projected to Reach $156.14 million by 2030 - Exclusive Report by 360iResearch
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

at 20:35
La Jolla Institute for Immunology and RevolKa started a Research Collaboration
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

at 19:05
U.S. FDA Approves Subcutaneous Administration of Takeda's ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn's Disease
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

at 18:42
Media Advisory - Minister Saks in Winnipeg to highlight Budget 2024: Fairness for Every Generation investments to boost research funding in Canada
The Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, will host an event at the University of Manitoba to highlight the federal budget's investments to boost funding for research in Canada. A media...

at 18:18
Targeting A Solution Panel Aims to Find Solutions for the Veteran Suicide Crisis with National Thought Leaders Tulsi Gabbard, Tim Kennedy, and Dan Hollaway
Targeting a Solution is an insightful and impactful fireside discussion dedicated to ending Veteran suicide that will have its next iteration on April 20th, 2024, in Kannapolis, NC hosted by The Independence Fund. The panel will feature four-term...

More news about Health...


News published on and distributed by: